SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-13-279812
Filing Date
2013-07-01
Accepted
2013-07-01 17:21:34
Documents
13
Period of Report
2013-06-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d551926d8k.htm 8-K 15831
2 EX-10.1 d551926dex101.htm EX-10.1 451606
3 GRAPHIC g551926bottom.jpg GRAPHIC 8880
4 GRAPHIC g551926ex101_pg40.jpg GRAPHIC 85367
5 GRAPHIC g551926ex101_pg41.jpg GRAPHIC 85650
6 GRAPHIC g551926ex101_pg42.jpg GRAPHIC 156953
7 GRAPHIC g551926ex101_pg43.jpg GRAPHIC 108265
8 GRAPHIC g551926ex101_pg44.jpg GRAPHIC 120064
9 GRAPHIC g551926ex101_pg53.jpg GRAPHIC 156718
10 GRAPHIC g551926ex101_pg69.jpg GRAPHIC 62801
11 GRAPHIC g551926ex101_pg72.jpg GRAPHIC 140402
12 GRAPHIC g551926ex101_pg73.jpg GRAPHIC 111231
13 GRAPHIC g551926ex101_pg74.jpg GRAPHIC 88334
  Complete submission text file 0001193125-13-279812.txt   2020117
Mailing Address 215 FIRST STREET SUITE 7 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 7 CAMBRIDGE MA 02142 617-444-8424
Sarepta Therapeutics, Inc. (Filer) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14895 | Film No.: 13945636
SIC: 2834 Pharmaceutical Preparations